Comments
Loading...
Blueprint Medicines (NASDAQ:BPMC) Stock, Insider Trading Activity
Blueprint Medicines: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Blueprint Medicines Corp Insiders Doing?
At Blueprint Medicines Corp, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 8.88K shares worth $1.71M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On December 16, 2024, Ariel Hurley, the company's PRINCIPAL ACCOUNTING OFFICER sold 219 shares for $54.13 each.
- On January 23, 2025, Kate Haviland, the company's CHIEF EXECUTIVE OFFICER sold 1.45K shares for $110.24 each.
- On December 2, 2024, Christina Rossi, the company's CHIEF OPERATING OFFICER sold 2.27K shares for $95.1 each.
Ownership Statistics for Blueprint Medicines Corp
Shares Outstanding
63.526M
Insider Shares Owned
1.362M
Insider Percentage Owned
2.14%
Institutional Shares Held
48.476M
Institutional Percentage Held
76.3%
Data brought to you by Benzinga APIs
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
BPMC Insider Trading News
No news found